Abstract
Candida albicans is an opportunistic fungal able to produces both superficial and systemic infections in immunocompromised patients. It has been demonstrated that biofilms formed by Candida albicans are resistant to different antifungal drugs, therefore, the infections related to biofilm formation are, frequently, refractory to the conventional therapy. Thus, the development of more effec…